Insmed Inc INSM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/05/22 EDT
27.75UNCH (UNCH)
Volume
64,505
Close
27.75quote price arrow up+2.69 (+10.73%)
Volume
2,171,414
52 week range
16.41 - 34.44
Loading...
  • Open24.67
  • Day High28.18
  • Day Low24.61
  • Prev Close25.06
  • 52 Week High34.44
  • 52 Week High Date11/04/21
  • 52 Week Low16.41
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap3.317B
  • Shares Out119.52M
  • 10 Day Average Volume1.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.89
  • YTD % Change1.87

KEY STATS

  • Open24.67
  • Day High28.18
  • Day Low24.61
  • Prev Close25.06
  • 52 Week High34.44
  • 52 Week High Date11/04/21
  • 52 Week Low16.41
  • 52 Week Low Date05/12/22
  • Market Cap3.317B
  • Shares Out119.52M
  • 10 Day Average Volume1.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.89
  • YTD % Change1.87

RATIOS/PROFITABILITY

  • EPS (TTM)-3.51
  • P/E (TTM)-7.90
  • Fwd P/E (NTM)-10.48
  • EBITDA (TTM)-370.761M
  • ROE (TTM)-272.23%
  • Revenue (TTM)201.35M
  • Gross Margin (TTM)76.91%
  • Net Margin (TTM)-217.35%
  • Debt To Equity (MRQ)673.00%

EVENTS

  • Earnings Date10/26/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Insmed Inc

There is no recent news for this security.

Profile

MORE
Insmed Incorporated is a biopharmaceutical company engaged in providing ARIKAYCE (amikacin liposome inhalation suspension) product, which is used for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its clinical-stage pipeline includes brensocatib and treprostinil palmitil inhalation powder (TPIP). Brensocatib is a small molecule, oral, reversible...
William Lewis
Chairman of the Board, President, Chief Executive Officer
Roger Adsett
Chief Operating Officer
Sara Bonstein
Chief Financial Officer
Address
700 Us Highway 202/206
Bridgewater, NJ
08807
United States

Top Peers

SYMBOLLASTCHG%CHG
TWST
Twist Bioscience Corp
52.77+5.94+12.68%
FOLD
Amicus Therapeutics Inc
12.18+1.24+11.33%
GBT
Global Blood Therapeutics Inc
63.84+15.85+33.03%
ARVN
Arvinas Inc
55.43+4.02+7.82%
BCRX
BioCryst Pharmaceuticals Inc
14.05+0.31+2.26%